Skip to main content

Advertisement

Announcing the launch of In Review

BMC Immunology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Featured article: Fighting cancer with the immune system

Studies have shown the immune system has the potential to remove tumor cells in a patient’s body. This article describes a method for generating antitumor  cytotoxic T lymphocytes (CTLs)  specific for the epitopes of the HER2/neu tumor-associated antigen. These CTLs are then shown to have a pronounced cytotoxic effect on tumor cells expressing the HER2/neu marker.

Read More

Articles

Most accessed articles RSS

View all articles

Aims and scope

BMC Immunology is an open access journal publishing original peer-reviewed research articles in molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system as well as clinical studies and animal models of human diseases.

Editor

  • Tim Shipley, BioMed Central

Section Editors

  • Simon R Carding, University of East Anglia
  • Lucienne Chatenoud, Hospital Necker
  • James Li, University of Hong Kong
  • J Philip McCoy, National Institutes of Health
  • Wayne Thomas, Institute for Child Health Research

Meet the Editors

Professor Wayne Thomas graduated with a PhD from the University of Western Australia in 1974.  In 1984, he began a program at the Telethon Kids Institute in Western Australia to provide the structural data of house dust mite allergens. He joined the Editorial Board of BMC Immunology in 2012.

Research Data Support

Authors submitting to this journal can opt to use a new service that will make it easier to share research data.

Find out more

Latest Tweets

Advertisement

2018 Journal Metrics

Advertisement